Status:
RECRUITING
Faecal Analyses in Spondyloarthritis Therapy
Lead Sponsor:
Region Skane
Conditions:
Spondyloarthropathies
Ankylosing Spondylitis
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the intestinal microbiome and disease activity in patients with spondyloarthropathies receiving immunosuppressive therapy. Patients will be analysed at two time points in referen...
Detailed Description
Tumor necrosis factor (TNF)-inhibition is an efficient medication for the treatment of spondyloarthropathy. In a substantial number of cases however, these medications remain ineffective. At present, ...
Eligibility Criteria
Inclusion
- Fulfilling the Assessment of SpondyloArthritis International Society classification criteria for spondyloarthropathy.
- About to commence treatment with TNF-inhibition
Exclusion
- Failure to understand protocol
- A history of alcohol abuse
- Any history of diverticulitis
- A history of failure to comply with prescribed medication
- Ongoing biological therapy
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03839862
Start Date
January 1 2019
End Date
December 31 2026
Last Update
March 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reumatologi SUS Lund, Region Skåne
Lund, Sweden, 221 85